Newborn screening for congenital hypothyroidism, Victoria, Australia, 1977-1997. Part 2: Treatment, progress and

J F Connelly1, A L Rickards, J C Coakley

  • 1Department of Clinical Biochemistry, Royal Children 's Hospital, Parkville, Victoria, Australia. connelly@labyrinth.net.au

Insights

Congenital hypothyroidism (CH) detected by newborn screening did not affect linear growth in children. However, cognitive outcomes were slightly lower, with significant influencing factors including maternal education and socioeconomic status.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Neurodevelopmental Pediatrics

Background:

  • Congenital hypothyroidism (CH) is a condition detected through newborn screening.
  • Early detection and treatment are crucial for neurodevelopmental outcomes.

Purpose of the Study:

  • To assess the long-term physical and neuropsychological development of children with CH.
  • To identify factors influencing cognitive outcomes in children with CH.

Main Methods:

  • A controlled longitudinal prospective study of 152 children with CH detected via newborn screening.
  • Physical growth and neuropsychological assessments were conducted up to 12 years.
  • Cognitive outcomes were compared to a control group of 60 euthyroid children.

Main Results:

  • Children with CH exhibited normal linear growth but slightly higher weight and head circumference.
  • Cognitive scores at 2, 5, and 8 years were significantly lower (8.5–10.2 points) than controls, with a large overlap.
  • Univariate and multiple regression analyses identified baseline bone age, maternal age and education, and serious accompanying disorders as significant factors influencing cognitive outcome.

Conclusions:

  • While CH treatment normalizes physical growth, subtle cognitive deficits may persist.
  • Maternal factors and co-occurring disorders significantly impact cognitive outcomes in CH.
  • No single thyroid-related variable fully explains cognitive discrepancies.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...